ProfileGDS4718 / 1554485_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 95% 65% 93% 96% 83% 77% 94% 98% 96% 92% 98% 71% 85% 82% 61% 94% 73% 79% 35% 91% 93% 97% 95% 88% 86% 95% 71% 97% 83% 76% 57% 97% 95% 64% 82% 84% 89% 96% 57% 97% 78% 78% 86% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.6978292
GSM549102patient 115, normal, homogenized [OPG study]10.222795
GSM549104patient 119, normal, homogenized [OPG study]6.520565
GSM549108patient 138, normal, homogenized [OPG study]9.812793
GSM549119patient 077, normal, homogenized [OPG study]10.594396
GSM549133patient 032, cancer, homogenized [OPG study]8.3749583
GSM549139patient 042, cancer, homogenized [OPG study]7.5229877
GSM549099patient 107, normal, homogenized [OPG study]9.9784494
GSM549109patient 139, normal, homogenized [OPG study]11.506498
GSM549110patient 046, normal, homogenized [OPG study]10.754396
GSM549114patient 063, normal, homogenized [OPG study]9.7206192
GSM549122patient 082, normal, homogenized [OPG study]11.258998
GSM549134patient 033, cancer, homogenized [OPG study]6.9343971
GSM549136patient 036, cancer, homogenized [OPG study]8.5204885
GSM549140patient 044, cancer, homogenized [OPG study]8.2332982
GSM549111patient 047, normal, homogenized [OPG study]6.2051761
GSM549113patient 057, normal, homogenized [OPG study]10.239494
GSM549132patient 031, cancer, homogenized [OPG study]7.2100273
GSM549137patient 038, cancer, homogenized [OPG study]7.7854279
GSM549142patient 047, cancer, homogenized [OPG study]4.8645435
GSM549100patient 110, normal, homogenized [OPG study]9.3924491
GSM549107patient 135, normal, homogenized [OPG study]9.8484193
GSM549115patient 068, normal, homogenized [OPG study]11.10397
GSM549116patient 072, normal, homogenized [OPG study]10.413995
GSM549120patient 078, normal, homogenized [OPG study]8.8919188
GSM549131patient 030, cancer, homogenized [OPG study]8.6705686
GSM549118patient 074, normal, homogenized [OPG study]10.194595
GSM549129patient 027, cancer, homogenized [OPG study]6.9850871
GSM549123patient 088, normal, homogenized [OPG study]10.825897
GSM549124patient 006, cancer, homogenized [OPG study]8.1682683
GSM549126patient 015, cancer, homogenized [OPG study]7.3990676
GSM549128patient 025, cancer, homogenized [OPG study]5.9433557
GSM549103patient 117, normal, homogenized [OPG study]10.774797
GSM549117patient 073, normal, homogenized [OPG study]10.483495
GSM549138patient 041, cancer, homogenized [OPG study]6.4429764
GSM549141patient 045, cancer, homogenized [OPG study]8.1933182
GSM549130patient 028, cancer, homogenized [OPG study]8.329784
GSM549101patient 111, normal, homogenized [OPG study]9.0113889
GSM549105patient 128, normal, homogenized [OPG study]10.483596
GSM549106patient 134, normal, homogenized [OPG study]5.8909557
GSM549112patient 048, normal, homogenized [OPG study]10.920597
GSM549125patient 011, cancer, homogenized [OPG study]7.6364978
GSM549127patient 024, cancer, homogenized [OPG study]7.6991678
GSM549135patient 035, cancer, homogenized [OPG study]8.6975686